Search results
ASCO24: MSD’s ADC shows efficacy in lung and breast tumours
Pharmaceutical Technology· 5 days agoThe 63 patients in cohort 1B who only had a median follow up of only 6.9 months, did not reach...
It's about can, not Cannes
The Economic Times· 3 days agoAccording to a 2024 Dentsu India report, the advertising industry is poised to grow at 9.86% CAGR by 2025, thus reaching ₹1.12 lakh cr. The Indian D2C...
Paul DeJong homers as the White Sox beat the Rockies 11-3 for their 3rd straight win
NBC Sports Chicago· 23 hours agoCHICAGO (AP) — Paul DeJong homered and drove in three runs, and the Chicago White Sox beat the...
Totino's Pizza Roll Flavors, Ranked Worst To Best
Mashed· 6 days agoTotino's Pizza Rolls are a lifesaver when you're in a rush or have impromptu guests over to watch the game. Find out how the 10 flavors rank from worst...
Mets Midseason Top 30 prospects for 2024 season
SNY· 6 days agoINF Luisangel Acuña After a tough start to his Triple-A season, Acuña has turned it on over the last two months. Since May 1, he is slashing...
Murder case: SC extends BSP leader’s interim bail till July 26 | Central India's Premier English...
Central Chronicle· 2 days agoNew Delhi, June 28 (UNI) The Supreme Court on Friday extended till July 26 the interim bail granted to Bahujan Samaj Party (BSP) leader and former Uttar Pradesh MLA Uday Bhan Singh in a < ...
Giant firms push Japan to accelerate renewables adoption
Semafor· 5 days ago9 billion in Japanese facilities where fossil fuels will primarily power the centers. Nvidia and the...
Rahul’s growing stature comes with its share of challenges
The Week· 19 hours agoCONGRESS LEADER RAHUL GANDHI recently had an interaction with students protesting the malpractices...
France votes in snap parliamentary elections: Who's in the running? What's at stake?
Firstpost· 17 hours agoToday (June 30) is one of France’s most consequential political moments in recent history, as it...
ASCO24: MSD’s ADC shows efficacy in lung and breast tumours
Clinical Trials Arena· 5 days agoThe 63 patients in cohort 1B who only had a median follow up of only 6.9 months, did not reach...
